@mmasnick Thanks for your excellent coverage of the Labrador Diagnostics vs Biofire Diagnostics patent trolling lawsuit! After seeing your article, we decided to dig a little deeper into their patents. Spoiler alert: not a whole lot going on.
https://t.co/ocBdxJobDF
@mmasnick Thanks for your excellent coverage of the Labrador Diagnostics vs Biofire Diagnostics patent trolling lawsuit! After seeing your article, we decided to dig a little deeper into their patents. Spoiler alert: not a whole lot going on.
https://t.co/ocBdxJobDF
Our indexes in the media:
Read the op-ed from Ataman Ozyildirim, the Senior Director of Economics and Chair of Global Research with our partners at @Conferenceboard
https://t.co/75hSbjrfKM
You may have seen our funds launch on Wednesday - #INAU, #INAG, #TWAR, and be asking yourself - WTF? What's the fund? Good question! Here's our CEO, @monkeyking67, explaining on the NYSE trading floor:
M·CAM releases Patently Obvious® report examining the commercial fitness of patents held by US Steel @U_S_Steel . Read the full report at: https://t.co/dZwnXGWZWz #TradeWar#China#OpenInnovation
M·CAM releases Patently Obvious® report examining the commercial fitness of patents held by Eli Lilly @LillyPad . Read the full report at: https://t.co/5eCI4gz0e3
#WorldIPDay#OpenInnovation#TradeWar
M·CAM releases Patently Obvious® report examining the commercial fitness of patents held by Koch Industries. Read the full report at: https://t.co/zE2H8vHlwz
M·CAM releases Patently Obvious® report examining the commercial fitness of patents held by AstraZeneca. Read the full report at: https://t.co/zC31wrhuOf
On August 14, 2017, U.S. President Donald Trump released a document he neither read nor understood. In the Presidential Memorandum for the United States Trade Representative, he recited the tired echoes of the 34th... https://t.co/cUx7ncF4kE
M·CAM's Dr. David Martin attended #AfCFTA2018 in Kigali, Rwanda earlier this week. The missing piece in the dialogue about African Free Trade: technology transfer and the Global Innovation Commons @InnoCommons